Evidence map›Paper›PMID 26221912›Full record

ArticleAnalytical chemistry2015

Analysis of a common cold virus and its subviral particles by gas-phase electrophoretic mobility molecular analysis and native mass spectrometry.

Victor U Weiss, Jessica Z Bereszcazk, Marlene Havlik, Peter Kallinger, Irene Gösler, Mohit Kumar, Dieter Blaas, Martina Marchetti-Deschmann, Albert J R Heck, Wladyslaw W Szymanski and 1 more

Open access · hybridAbstract read
In one paragraph

Article in Analytical chemistry, 2015. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 33 papers.

0numbers the graph read from it
0cells of the map it votes in
33citing papers in PubMed
4.4field-weighted citation impact, top 7% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

33 citing papers in PubMed, 43 citations in OpenAlex.

  1. Article
  2. Article
  3. Article
  4. Article
  5. Review
  6. Single particle charge detection mass spectrometry enables molecular characterization of lipid nanoparticles and mRNA packaging.Journal of controlled release : official journal of the Controlled Release Society · 2025
    Article
  7. Article
  8. Article
  9. Article
  10. Article
  11. Review
  12. Article
  13. Article
  14. Article
  15. Review
  16. Article
  17. Review
  18. Article
  19. Article
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

11 authors at 5 institutions in 2 countries.

Victor U WeissInstitute of Chemical Technologies and Analytics, TU Wien , Getreidemarkt 9/164, A-1060 Vienna, Austria.
Jessica Z BereszcazkBijvoet Centre for Biomolecular Research and Utrecht Institute of Pharmaceutical Sciences, Utrecht University , NL-3584 CH Utrecht, The Netherlands.
Marlene HavlikInstitute of Chemical Technologies and Analytics, TU Wien , Getreidemarkt 9/164, A-1060 Vienna, Austria.
Peter KallingerFaculty of Physics, University of Vienna , A-1090 Vienna, Austria.
Irene GöslerDepartment of Medical Biochemistry, Max F. Perutz Laboratories, Medical University of Vienna, Vienna Biocenter (VBC) , A-1030 Vienna, Austria.
Mohit KumarDepartment of Medical Biochemistry, Max F. Perutz Laboratories, Medical University of Vienna, Vienna Biocenter (VBC) , A-1030 Vienna, Austria.
Dieter BlaasDepartment of Medical Biochemistry, Max F. Perutz Laboratories, Medical University of Vienna, Vienna Biocenter (VBC) , A-1030 Vienna, Austria.
Martina Marchetti-DeschmannInstitute of Chemical Technologies and Analytics, TU Wien , Getreidemarkt 9/164, A-1060 Vienna, Austria.
Albert J R HeckBijvoet Centre for Biomolecular Research and Utrecht Institute of Pharmaceutical Sciences, Utrecht University , NL-3584 CH Utrecht, The Netherlands.
Wladyslaw W SzymanskiFaculty of Physics, University of Vienna , A-1090 Vienna, Austria.
Günter AllmaierInstitute of Chemical Technologies and Analytics, TU Wien , Getreidemarkt 9/164, A-1060 Vienna, Austria.
TU Wien · ATUniversity of Vienna · ATUtrecht University · NLVienna Biocenter · ATMedical University of Vienna · AT

Funding

Austrian Science Fund FWF P 25749
6 · The paper itself

Abstract

Gas-phase electrophoretic mobility molecular analysis (GEMMA) separates nanometer-sized, single-charged particles according to their electrophoretic mobility (EM) diameter after transition to the gas-phase via a nano electrospray process. Electrospraying as a soft desorption/ionization technique preserves noncovalent biospecific interactions. GEMMA is therefore well suited for the analysis of intact viruses and subviral particles targeting questions related to particle size, bioaffinity, and purity of preparations. By correlating the EM diameter to the molecular mass (Mr) of standards, the Mr of analytes can be determined. Here, we demonstrate (i) the use of GEMMA in purity assessment of a preparation of a common cold virus (human rhinovirus serotype 2, HRV-A2) and (ii) the analysis of subviral HRV-A2 particles derived from such a preparation. (iii) Likewise, native mass spectrometry was employed to obtain spectra of intact HRV-A2 virions and empty viral capsids (B-particles). Charge state resolution for the latter allowed its Mr determination. (iv) Cumulatively, the data measured and published earlier were used to establish a correlation between the Mr and EM diameter for a range of globular proteins and the intact virions. Although a good correlation resulted from this analysis, we noticed a discrepancy especially for the empty and subviral particles. This demonstrates the influence of genome encapsulation (preventing analytes from shrinking upon transition into the gas-phase) on the measured analyte EM diameter. To conclude, GEMMA is useful for the determination of the Mr of intact viruses but needs to be employed with caution when subviral particles or even empty viral capsids are targeted. The latter could be analyzed by native MS.

Indexed as

Electrophoretic Mobility Shift AssaySpectrometry, Mass, Electrospray IonizationHumansRhinovirusVirionVirology

Identifiers

PMID26221912
PMCPMC4558612
OpenAlexW1739220256

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.